-   Training & Support

[Expand/Collapse all sections]Expand all

This document outlines the Pharmaceutical Benefits Scheme (PBS)
subsidised teduglutide for patients with short bowel syndrome with
intestinal failure.

On this Page:

Short bowel syndrome with intestinal failure and listing dates

Short bowel syndrome with intestinal failure is a malabsorption disorder
caused by a lack of functional small intestine.

Listing dates for short bowel syndrome with intestinal failure:

-   teduglutide – 1 October 2019

Note: this item is only available for day admitted patients,
non-admitted patients or patients on discharge from an approved
hospital.

See Written Authority Required Drugs for more information.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Programs team and choose the team relevant to the condition
treated.

The Resources page contains links to restriction and item codes, contact
details, application forms, and the Pharmaceutical Benefits Scheme (PBS)
and Services Australia websites.

Related links

Written Authority Required Drugs

Processing Complex Authority Required Listings

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA)

                                   

-   Services Australia ABN 90 794 605 008 
